This article explores chloroquine use for prophylactic prevention of SARS as well as for treatment and prevention of spread. The testing was done with chloroquine (CQ) on cell cultures. Hydroxychloroquine (HCQ) is a variant of CQ. COVID-19 is a SARS-like illness.
This article is in the NIH database. Thus we see that a potential treatment for COVID-19 was already known at the time SARS-CoV-2 was released.
Source:
- August 22, 2005. Martin J. Vincent, Eric Bergeron, Suzanne Benjannet, Bobbie R. Erickson, Pierre E. Rollin, Thomas G. Ksiazek, Nabil G. Seidah, and Stuart T. Nichol. “Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread.” Virology Journal 2 (1): 69.
https://doi.org/10.1186/1743-422X-2-69.
Research Journal.
One of the requirements for issuing an Emergency Use Authorization for a drug is that no other treatment be available. Not only was the use of CQ and HCQ not explored by the NIH or CDC during the initial phases of the COVID-19 outbreak; but, as we shall see, manipulated and fake research was created to motivate the blocking of its use. The media echoed these fake results to make them widely known. “Wrap Up” Smear tactics were used on HCQ. The prescribing of HCQ for COVID-19 was banned by governors in some states. Furthermore, during hearings for the vaccine Emergency Use Authorizations, the testimonies of doctors in the field who were successfully using HCQ-based protocols went ignored. Had the HCQ-based protocols been recognized as a viable treatment option, the Emergency Use Authorizations should never have been issued.